Latest Contracts News

Page 1 of 575
The US FDA has refused to lift the clinical hold on Argenica Therapeutics’ xaranetide stroke program, demanding a GLP rat neurotoxicity study and imposing a lower exposure limit than the company proposed for Phase 2b. Argenica plans to challenge parts of the assessment while pursuing regulatory submissions elsewhere.
Ada Torres
Ada Torres
19 Nov 2026
Resonance Health delivered a $1.5 million profit and positive operating cash flow in every quarter of FY26, while raising $6 million to accelerate three growth programmes. The challenge is replacing a MASH trial that generated 48% of last year’s revenue.
Ada Torres
Ada Torres
19 Nov 2026
AUCyber has emerged from a lower-revenue FY26 with a sharper focus on managed cybersecurity, reporting a $4.7 million improvement in underlying EBITDA and $1.34 million of new university-sector ARR. The company is now targeting MSP acquisitions, a larger SOC operation and sovereign AI services, while a $5.5 million university tender remains uncontracted.
Victor Sage
Victor Sage
19 Nov 2026
PlaySide Studios has emerged from a difficult year with a sharp EBITDA recovery, more than 1 million MOUSE sales and A$7.3 million of new FY27 external-project contracts. Its next test is converting that momentum into a successful Game of Thrones launch and more durable cash flow.
Victor Sage
Victor Sage
19 Nov 2026
Temas Resources has secured an estimated C$52,876 Stage 1 contract to test its Regenerative Chloride Leach technology on samples from an unnamed Québec mineral company. The nearby project could offer a regional processing opportunity, while a new governance appointment reshapes the board.
Victor Sage
Victor Sage
19 Nov 2026
Eden Innovations received US$538,896 of EdenCrete orders in the first seven weeks of Q2 FY27, more than four times Eden US sales in the preceding quarter. The figure includes a previously announced Holcim Ecuador order, while four new dispensing installations expand the base supporting future replenishment demand.
Victor Sage
Victor Sage
19 Nov 2026
FortifAI has appointed former NVIDIA and Elastic sales leader Jason Brushe as CEO, putting commercial partnerships at the centre of NOL8’s next phase. His package includes US$300,000 in annual remuneration and performance rights tied to agreements, partnerships and bookings milestones.
Sophie Babbage
Sophie Babbage
19 Nov 2026
Lifestyle Communities has entered FY27 with a substantially stronger balance sheet, after cutting net debt by $186.8 million and unsold inventory by 55% in FY26. The company says demand remains resilient, but slower Victorian property activity is stretching settlement timelines and tempering its next growth phase.
Eva Park
Eva Park
19 Nov 2026
Chrysos Corporation (ASX:C79) has reported a strong opening four months of FY27, with unaudited revenue up 27% and PhotonAssay sample volumes up 43%. The company reaffirmed its full-year guidance while expanding its deployed fleet and contracted pipeline.
Victor Sage
Victor Sage
19 Nov 2026
Worley has reaffirmed mid to high single-digit growth expectations for FY2027 despite a weaker FY2026, while shareholders delivered a strong protest vote on executive remuneration. The AGM also began the search for a successor to long-serving Chair John Grill.
Victor Sage
Victor Sage
19 Nov 2026
Everpure delivered a sharp acceleration in fiscal Q3, with revenue rising 51% to US$1.46 billion and management lifting its full-year targets for the third consecutive quarter. Subscription growth, AI infrastructure demand and a second top-five hyperscaler design win strengthened the company’s growth narrative.
Sophie Babbage
Sophie Babbage
19 Nov 2026
Allied Farmers expects FY27 operating profit after tax to fall materially after the NZ Farmers Livestock sale and a one-off tax benefit drop out. The company is reviewing whether to invest its cash, sell assets or return capital to shareholders.
Victor Sage
Victor Sage
19 Nov 2026

Browse the archive

Full archive